MedTrace Logo

CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer

NCT04710589 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-01-14

No results posted yet for this study

Summary

This study is to explore the progression-free survival time (PFS) , overall survival time (OS), quality of life and side effects between two different clinical target volumes in the treatment of 3D printing template-assisted CT-guided radioactive iodine-125 seeds implantation for recurrent rectal cancer after surgery and radiotherapy and investigate the clinical and dosimetric prognosis factors for outcomes.

Conditions

  • Recurrent Rectal Cancer
  • 125I Seeds Implantation
  • Clinical Target Volume

Interventions

RADIATION

CTV

According to the clinical conditions of the patients, they will be assigned to two groups based on the doctor's recommendations and their own wishes

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710589 on ClinicalTrials.gov